Literature DB >> 11232150

ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation?

D Farquhar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11232150      PMCID： PMC80756     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1997-05-31       Impact factor: 79.321

Review 2.  Antithrombotic therapy in atrial fibrillation.

Authors:  A G Turpie; S J Connolly
Journal:  Can Fam Physician       Date:  1996-07       Impact factor: 3.275

3.  Low-molecular-weight heparin for the treatment of acute ischemic stroke.

Authors:  R Kay; K S Wong; Y L Yu; Y W Chan; T H Tsoi; A T Ahuja; F L Chan; K Y Fong; C B Law; A Wong
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Cardioembolic stroke, early anticoagulation, and brain hemorrhage. Cerebral Embolism Study Group.

Authors: 
Journal:  Arch Intern Med       Date:  1987-04

5.  Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

Authors:  P Sandercock; J Bamford; M Dennis; J Burn; J Slattery; L Jones; S Boonyakarnkul; C Warlow
Journal:  BMJ       Date:  1992-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.